Vectorial import via a metastable disulfide-linked complex allows for a quality control step and import by the mitochondrial disulfide relay by Habich, Markus et al.
ArticleVectorial Import via a Metastable Disulfide-Linked
Complex Allows for aQuality Control Step and Import
by the Mitochondrial Disulfide RelayGraphical AbstractHighlightsd IMS import by the disulfide relay proceeds via formation of a
covalent intermediate
d Import is driven by hydrophobic and disulfide-dependent
interactions
d The covalent intermediate is also formed by oxidation-
incompetent substrates
d Redox quality control allows for IMS substrate release and
proteasomal degradationHabich et al., 2019, Cell Reports 26, 759–774
January 15, 2019 ª 2018 The Author(s).
https://doi.org/10.1016/j.celrep.2018.12.092Authors
Markus Habich, Silja Lucia Salscheider,
Lena Maria Murschall, ..., Hamid Kashkar,
Joern Dengjel, Jan Riemer
Correspondence
jan.riemer@uni-koeln.de
In Brief
Disulfide formation in the mitochondrial
intermembrane space (IMS) is an
essential process that is coupled to
protein import. Here, Habich et al. report
on a redox quality control step in which
the import competence of substrates is
tested, and when it fails, substrates are
released to the cytosol for degradation.
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Disulfide formation in the mitochondrial intermem-
brane space (IMS) is an essential process. It is cata-
lyzed by the disulfide relaymachinery, which couples
substrate import and oxidation. The machinery relies
on the oxidoreductase and chaperone CHCHD4-
Mia40. Here, we report on the driving force for IMS
import and on a redox quality control mechanism.
We demonstrate that unfolded reduced proteins,
upon translocation into the IMS, initiate formation
of a metastable disulfide-linked complex with
CHCHD4. If this interaction does not result in produc-
tive oxidation, then substrates are released to the
cytosol and degraded by the proteasome. Based
on these data, we propose a redox quality control
step at the level of the disulfide-linked intermediate
that relies on the vectorial nature of IMS import.
Our findings also provide the mechanistic framework
to explain failures in import of numerous human
disease mutants in CHCHD4 substrates.INTRODUCTION
In human cells, proteins of the mitochondrial intermembrane
space (IMS) fulfil essential functions in calcium signaling, respira-
tory chain assembly, hypoxia response, and apoptosis signaling.
IMS proteins are synthesized by cytosolic ribosomes and are
imported into the IMS by dedicated machineries. Many IMS
proteins rely not on classical bipartite mitochondrial targeting
sequences (MTSs) for their import but, instead, on conserved
cysteines that are arranged in specific patterns (Chatzi et al.,
2016; Endo et al., 2010; Erdogan and Riemer, 2017; Harbauer
et al., 2014; Wasilewski et al., 2017).
These proteins are substrates of the mitochondrial disulfide
relay; more specifically, of the IMS import receptor and oxidore-Cell
This is an open access article under the CC BY-Nductase CHCHD4 (also human Mia40; in yeast, Mia40) (Banci
et al., 2009, 2010; Fischer et al., 2013; Hofmann et al., 2005; Me-
secke et al., 2005). CHCHD4 is an unusual oxidoreductase. Un-
like oxidoreductases from other oxidizing compartments, like the
endoplasmic reticulum or the bacterial periplasm, CHCHD4
does not consist of one or more thioredoxin-like domains but,
instead, uses a minimal helix-turn-helix fold containing a hydro-
phobic groove with chaperone function for substrate interaction
(Banci et al., 2009, 2010; Kawano et al., 2009; Koch and Schmid,
2014a). Connected to this fold is a short helix with the redox-
active cysteine-proline-cysteine motif (C53 and C55 of human
CHCHD4). The N- and C-terminal regions of CHCHD4 are un-
structured. At least in vitro, they are not required for CHCHD4
function, and a truncated human CHCHD4 can functionally
replace Mia40 in yeast cells (Chacinska et al., 2008; Sztolsztener
et al., 2013). However, in intact mammalian cells, the N-terminal
region serves in the interaction with apoptosis-inducing factor
(AIF), which recently has been shown to be critical for the mito-
chondrial import of CHCHD4 (Hangen et al., 2015; Meyer et al.,
2015).
CHCHD4 substrates are synthesized by cytosolic ribosomes
as reduced precursors. In the cytosol, members of the glutare-
doxin family (in yeast, members of the thioredoxin family) main-
tain them in their reduced state (Banci et al., 2013; Durigon
et al., 2012). Additionally, at least in vitro, Zn2+ maintains sub-
strates in a reduced state (Morgan et al., 2009). In yeast, the
proteasome system fulfils a control function and removes parts
of newly producedMia40 substrates immediately after synthesis
(Bragoszewski et al., 2013; Kowalski et al., 2018). It is not known
whether this is also the case in mammalian cells.
During passage through the translocase of the outer mem-
brane (TOM) pore, substrates already interact with CHCHD4 (Pe-
leh et al., 2016; von derMalsburg et al., 2011). The initiation of the
interaction between CHCHD4 and its substrates therefore
depends on two hydrophobic motifs. These motifs are placed
in an amphipathic helix that contains a conserved cysteine
residue. The first motif consists of hydrophobic residues posi-
tioned directly adjacent to this specific substrate cysteine.Reports 26, 759–774, January 15, 2019 ª 2018 The Author(s). 759
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In vitro experiments indicated that they initiate a loose non-cova-
lent interaction with the hydrophobic groove of CHCHD4 (Koch
and Schmid, 2014b). Subsequently, a hydrophobic patch in the
amphipathic helix of the substrate (also termed mitochondrial
IMS sorting signal [MISS] or IMS targeting signal [ITS]) that
serves as the second motif strengthens this non-covalent inter-
action (Koch and Schmid, 2014b; Milenkovic et al., 2009; Sideris
et al., 2009). Both non-covalent interactions initiate helix folding
and orient the substrate and, therefore, allow nucleophilic attack
of the thiolate anion of the substrate cysteine residue on
CHCHD4. This results in the formation of an intermolecular disul-
fide bond, likely via C55 of CHCHD4 (Banci et al., 2009; Koch and
Schmid, 2014a; Terziyska et al., 2009). This intermolecular disul-
fide bond is long-lived in vitro and in vivo compared with intermo-
lecular disulfide bonds that are formed during oxidative protein
folding in other compartments (Chacinska et al., 2004; Fischer
et al., 2013; Koch and Schmid, 2014a; Mesecke et al., 2005; Pet-
rungaro et al., 2015; Sideris et al., 2009). It has been proposed
that this is an adaptation to the coupling of vectorial import
and oxidative folding in the IMS that is not found in other
oxidizing compartments (Koch and Schmid, 2014a). The inter-
molecular disulfide is resolved by a second nucleophilic attack
from a cysteine of the substrate, which leads to the formation
of a disulfide bond in the substrate. The importance of CHCHD4
for substrate import is illustrated by the fact that depletion of
CHCHD4 results in loss of its substrates (Fischer et al., 2013;
Hangen et al., 2015; Hofmann et al., 2005; Meyer et al., 2015).
Likewise, also in yeast, depletion of Mia40 prevents efficient
mitochondrial substrate accumulation (Chacinska et al., 2004;
Mesecke et al., 2005).
The precise mechanism of vectorial disulfide relay-mediated
IMS import remains debated. Initial models based mainly on
in vitro import experiments in yeast suggested a pathway in
which disulfide formation between the substrate and Mia40
leads to directed diffusion of the substrate into the IMS (Mile-
nkovic et al., 2009; Sideris et al., 2009; von der Malsburg et al.,
2011). However, these experiments neglected the reducing
influences of the cytosol and IMS, the competition of different
substrates for import, the chaperone function of Mia40, and
the extremely low import efficiency of in organello import ap-
proaches compared with the highly efficient IMS import in intact
cells (Fischer et al., 2013; Kojer et al., 2015). An alternativemodel
proposed that disulfide formation is negligible for protein import
and only a consequence of a preceding chaperone-like ‘‘pulling’’
of the substrate by Mia40 that solely relies on hydrophobic inter-
actions (Baker et al., 2012; Peleh et al., 2016; Weckbecker et al.,
2012). The latter ‘‘trans-site receptor’’ model is based on the fact
that the MISS/ITS signal of disulfide relay substrates is both
necessary and sufficient for targeting proteins into yeast mito-
chondria in vitro, although, again, the import efficiencies of the
respective approaches were very low (Milenkovic et al., 2009;
Sideris et al., 2009). Moreover, genetic separation of the oxido-
reductase and chaperone function of Mia40 suggested that the
oxidoreductase function might not be essential, although the
respective experiments were performed in the presence of
high amounts of oxidant (Peleh et al., 2016).
The trans-site receptor model is contradicted by work in
intact cells. Expression of a redox-inactive CHCHD4 mutant760 Cell Reports 26, 759–774, January 15, 2019(C53S,C55S) in human cells abolished the import and oxida-
tion of selected substrate precursors, although the hydropho-
bic interaction between the substrate and CHCHD4 was not
targeted (Fischer et al., 2013). Additionally, disease mutants
like NDUFB10C107S (Friederich et al., 2017) and TIMM8C66W
(Hofmann et al., 2002) demonstrated the importance of sub-
strate cysteines because they also fail to accumulate in
mitochondria.
To reconcile these apparently exclusive findings and
address the important question of how the disulfide relay pop-
ulates the IMS in intact cells as well as to provide a framework
for why disease mutants of CHCHD4 substrates fail to accu-
mulate in the IMS, we revisited the mechanisms of disulfide
relay-dependent import in intact mammalian cells. A series
of dynamic pulse-chase and proteomic approaches allowed
observation of vectorial transport with the correct stoichiom-
etry between the substrate and CHCHD4, the correct spatio-
temporal setting of events, in the endogenous redox milieu of
the IMS and the cytosol. With our approaches, we demon-
strated the formation of a metastable disulfide-linked interme-
diate between CHCHD4 and the translocating substrate. This
intermediate is also formed by substrate variants, including
patient mutants, that do not become oxidized and do not
accumulate in mitochondria and by CHCHD4 variants that
fail to oxidize their substrates. At the level of this intermediate,
a decision is made for either productive mitochondrial protein
import and oxidation or—if oxidation does not proceed effi-
ciently—substrate release to the cytosol and proteasomal
degradation of the unfolded precursor. Thus, the disulfide
relay itself provides a layer of quality control for its substrates
and determines whether they are competent for folding and
import.
RESULTS
In Intact Cells, Cysteine Variants of COX19 Fail to
Become Oxidized Despite Formation of Mixed Disulfide
Intermediates with CHCHD4
First we explored the spatiotemporal importance of cysteines
and hydrophobic interactions in the human disulfide relay by
analyzing cysteine mutants in disulfide relay substrates. We
thereforemainly focused on selectedmodel twin CX9C substrate
proteins (COX19, COA4, and NDUFB10; Figure S1A). Although
IMS proteins that rely on different cysteine motifs for import
and oxidative folding have been identified (Barchiesi et al.,
2015; Petrungaro et al., 2015; Weckbecker et al., 2012), the ma-
jority of known CHCHD4 substrates are members of the twin
CX9C family (Cavallaro, 2010; Fischer et al., 2013; Petrungaro
et al., 2015). We generated different HEK293 cell lines that
express, in a stable and inducible fashion, hemagglutinin (HA)-
tagged substrate variants of COX19, COA4, and NDUFB10.
This ensures comparatively low expression levels that lead to
full accumulation of wild-type proteins in mitochondria (Fischer
et al., 2013). For COX19, we mutated the cysteines that, in the
mature protein, form the outer disulfide (C30S,C61S) or the inner
disulfide (C40S,C51S). For COA4, we generated a quadruple
cysteine mutant to alanine that renders the protein even more
hydrophobic, and for NDUFB10, we generated the C107S
(legend on next page)
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mutant, which corresponds to a patient mutation (Friederich
et al., 2017; Figure S1A).
Mechanistically, disulfide-linked interaction between
CHCHD4 and substrates is the first step in oxidative folding.
To test whether COX19 variants form disulfide-linked inter-
mediates with CHCHD4 during their biogenesis in intact cells,
we employed a pulse-chase assay followed by denaturing
immunoprecipitation (IP) against CHCHD4 and a subsequent
denaturing re-IP against the different COX19 variants (Fig-
ure 1A). Notably, except for the cysteine-free quadruple mutant
of COX19, all variants of COX19 did covalently interact with
CHCHD4 (Figure 1B). Wild-type NDUFB10 and the C107S
mutant also interacted with CHCHD4 (Figure S1B). Thus, sub-
strates, even when they do not contain the full set of cysteines,
traverse the TOM pore and initiate interaction with CHCHD4. It
also indicates that not only the cysteine with an adjacent MISS/
ITS is capable of interaction with CHCHD4, but, instead, that
substrates exhibit a certain plasticity with respect to their
CHCHD4 interaction site. In line with this, we found that, for
most human twin CX9C proteins, both helices possess hydro-
phobic stretches that could serve as alternative CHCHD4 inter-
action sites (Figure S1C).
Does interaction of substrate cysteine variants with CHCHD4
result in productive oxidation? To test this, we assessed the
oxidation kinetics of newly synthesized COX19. To this end,
we employed an oxidation assay in which we coupled a
pulse-chase assay to redox state determination and IP of the
protein of interest (Fischer et al., 2013; Figure 1C). Although
wild-type COX19 quickly became oxidized, all cysteine variants
remained completely reduced over the course of the experi-
ment (Figure 1D). This is contradictory to in vitro experiments
in which COX19 cysteine variants did become oxidized by
CHCHD4 and also formed mixed disulfide intermediates (BienFigure 1. Despite Interaction with CHCHD4, COX19 Cysteine Variants
(A) In vivo CHCHD4-substrate interaction assay. HEK293 cells stably expressing
exchange reactions were inhibited by addition of n-ethylmaleimide (NEM) to pre
precipitation (IP) against CHCHD4 enriched monomeric CHCHD4 and mixed disu
second IP (re-IP) against the HA tag of COX19-HA variants. This mixed disulfi
autoradiography.
(B) Interaction between CHCHD4 and COX19 cysteine variants, performed as des
was induced during the 4-h pulse with 1 mg/mL doxycycline. CHCHD4 interact
suggests that many twin CX9C substrate proteins contain multiple sites for inter
reducing SDS-PAGE; red arrow, disulfide-linked CHCHD4-COX19 dimer; blue ar
dimer, possibly with truncated CHCHD4; +, COX19 not in the disulfide-linked co
(C) In vivo oxidation assay to follow oxidative folding in intact cells. Cells are pul
different times. The chase is stopped by trichloroacetic acid (TCA) precipitation,
sulfonic acid (AMS) to determine protein redox states, followed by IP against t
Reduced COX19 is modified with four AMS, whereas oxidized COX19 remains u
(D) In vivo oxidation assay with HEK293 cells stably expressing different cystei
Performed as described in (C). Expression was induced 1 h before the experime
(E) Localization of MTS-COX19 cysteine variants. COX19 cysteine variants carryi
the indicated MTS-COX19-HA variants were incubated for 24 h with 1 mg/mL dox
using primary antibodies against the HA epitope (aHA, green) and cytochrome
fluorescence microscopy. Scale bar, 10 mm. n = 6–9 cells, 2 biological replicates
(F) Oxidation kinetics of MTS-COX19-HA wild-type protein. Addition of a cleava
described in (C). n = 2 biological replicates.
(G) Oxidation kinetics of MTS-COX19-HA cysteine variants. Addition of a cleavab
described in (C). n = 2 biological replicates.
(H) Quantification of (F) and (G). Quantification was performed in ImageJ.
762 Cell Reports 26, 759–774, January 15, 2019et al., 2010; Figures S1D–S1I). Thus, in intact cells, interaction
of the substrate and CHCHD4 is not predictive of oxidative
folding.
Additionally, we tested whether forced import of COX19 into
the IMS by equipping it with an MTS would allow oxidation of
COX19 cysteine variants. To this end, we generated stable
cell lines expressing COX19C30S,C61S, COX19C40S,C51S, or
COX19C30S,C40S,C51S,C61S fused to the bipartite MTS of the
soluble protein SMAC (MTS-COX19 variants). Like MTS-
COX19WT, all MTS cysteine variants co-localized with mito-
chondria in immunofluorescence (Figure 1E). As shown
previously, oxidation of wild-type COX19 was slightly acceler-
ated when fused to this MTS (Fischer et al., 2013; Figure 1F).
However, when we performed the oxidation assay with both
MTS cysteine variants, we observed that these proteins did
not become oxidized (Figures 1G and 1H). Instead, they ap-
peared to be destabilized (compare with Figure 1D).
Taken together, COX19 cysteine variants, even when effi-
ciently targeted to the IMS, are not oxidized in intact cells.
In vitro, the proteins still have the capacity to interact
with CHCHD4 and become oxidized by it (Figure S1). How-
ever, in the in vivo situation with its vectorial import and
reducing redox milieu, non-productive oxidation is prevented
despite an initial covalent interaction between the substrate
and CHCHD4 (Fischer et al., 2013; Kojer et al., 2012;
Figure 1B).
Interaction with CHCHD4 Does Not Result in
Mitochondrial Retention of COX19 Cysteine Variants
Do substrates that interact with CHCHD4 but fail to become
oxidized still accumulate in mitochondria? In other words, is
the hydrophobic interaction with CHCHD4 sufficient to pull sub-
strates into the IMS? To test this, we analyzed the mitochondrialFail to Become Oxidized in Intact Cells
COX19-HA variants were pulse-labeled with 35S-methionine for 4 h. Then thiol
serve mixed disulfides. Cells were lysed in SDS, and a denaturing immuno-
lfides of COX19-HA variants bound to CHCHD4. The latter were isolated by a
de was analyzed in non-reducing or reducing SDS-PAGE and visualized by
cribed in (A). 1% of the IP against CHCHD4was loaded as a control. Expression
s covalently with different COX19 cysteine variants in vivo. In silico analysis
action with CHCHD4 (Figure S1C). Red, reducing SDS-PAGE; non-red, non-
row, COX19; asterisk, background band; #, disulfide-linked CHCHD4-COX19
mplex. n = 2 biological replicates.
se-labeled for 5 min with 35S-methionine and chased with cold methionine for
and then the lysate is treated with 4-acetamido-4-maleimidylstilbene-2,2-di-
he HA tag. Eluates are analyzed by Tris-Tricine-PAGE and autoradiography.
nmodified.
ne variants of COX19-HA. COX19 cysteine variants are not oxidized in vivo.
nt with 1 mg/mL doxycycline. n = 2 biological replicates.
ng the MTS of SMAC localize to mitochondria. HEK293 cells stably expressing
ycycline to induce expression. Cells were fixated, permeabilized, and stained
c (acyt c, red). Nuclei were stained with DAPI (blue). Cells were analyzed by
.
ble MTS allows oxidation of processed wild-type COX19-HA. Performed as
le MTS does not result in oxidation of COX19 cysteine variants. Performed as
AB C
Figure 2. Interaction with CHCHD4 Does Not Result in Mitochondrial Retention of COX19 Cysteine Variants
(A) Immunofluorescence analyses of COX19-HA cysteine variants stably expressed in HEK293 cells. Performed as described in Figure 1E. Although COX19WT-
HA accumulates inmitochondria, neither of the cysteine variants does. Instead, they remain in the cytosol. Scale bar, 10 mm. n = 7–10 cells, 2 biological replicates.
(B) In vivo fractionation assay to assess post-translational protein import. Expression was induced by doxycycline treatment for 1 h before the pulse-chase
experiment. Cells were first pulse-labeled for 5 min with 35S-methionine and then chased with cold methionine for 0 or 20 min. At the end of the chase, cells were
transferred to ice and incubated with a low concentration of digitonin for 10 min to selectively permeabilize the plasma membrane and leave the OMM intact. To
separate the mitochondrial from the cytosolic fraction, lysates were centrifuged, and COX19-HA variants were immunoprecipitated. Eluates were analyzed by
SDS-PAGE and autoradiography.
(C) Pulse-chase fractionation experiment of COX19-HA cysteine variants expressed in HEK293 cells. Although COX19WT-HA accumulates in mitochondria,
neither of the cysteine variants does so. Instead, they remain in the cytosol. Performed as described in (B); n = 2 biological replicates.accumulation of COX19, NDUFB10, and COA4 cysteine variants
in stable inducible HEK293 cells. When we tested the cellular
localization of these proteins by immunofluorescence, we
found that, at steady state, cysteine variants of COX19,
NDUFB10, and COA4 failed to co-localize with the mitochon-
drial marker protein cytochrome c. Instead, these variants
exhibited cytosolic staining (Figures 2A and S2A; Friederich
et al., 2017).
Next we assessed the fate of newly synthesized COX19 and
COA4 variants in a dynamic fractionation experiment. Withthis approach, we coupled a radioactive pulse-chase
approach to rapid cell fractionation and IP of the protein of in-
terest (Fischer et al., 2013; Figure 2B). Although wild-type
COX19 and COA4 appeared in the mitochondrial fraction after
20 min of chase time, the cysteine variants of both proteins re-
mained in the cytosolic fraction (Figures 2C and S2B).
Although the hydrophobic MISS/ITS motif was present in the
cysteine variants, and despite their initial interaction with
CHCHD4, substrate cysteine mutants failed to accumulate in
mitochondria.Cell Reports 26, 759–774, January 15, 2019 763
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Redox-Active Cysteines and the Hydrophobic Groove in
CHCHD4 Are Required for Formation of Mixed Disulfide
Intermediates with Substrates
The presence of all cysteines is required for efficient oxidation
and substrate accumulation in mitochondria. Therefore, it is
conceivable that formation of a covalent substrate-CHCHD4
complex also requires the presence of cysteines in CHCHD4.
However, recent studies emphasized the importance of the hy-
drophobic groove in CHCHD4 for substrate import (Banci
et al., 2010; Peleh et al., 2016). We thus next dissected ‘‘redox’’
and ‘‘chaperone’’ contributions of CHCHD4 for substrate
interaction and oxidation. To this end, we employed HEK293
cell lines stably expressing two sets of C-terminally Strep-
tagged CHCHD4 variants. The first set included the ‘‘redox-
incompetent’’ variants CHCHD4C53S, CHCHD4C55S, and
CHCHD4C53S,C55S. The second set encompassed the chap-
erone variants CHCHD4F68E and CHCHD4C53S, C55S, F68E with a
mutation in the hydrophobic binding groove of CHCHD4 (Fig-
ure 3A). In yeast, different mutations of the hydrophobic binding
groove of CHCHD4 have been investigated. The F315E,F318E
Mia40 mutant has been shown to be strongly impaired in sub-
strate interaction, oxidation, and import (Kawano et al., 2009;
Peleh et al., 2016). However, these mutations change the imme-
diate surroundings of a structural cysteine of Mia40. We deemed
it possible that the corresponding mutant might abrogate mito-
chondrial import of CHCHD4, which, in human cells, depends
on its own machinery and the protein AIF and not on the MTS
pathway as in yeast (Hangen et al., 2015; Sztolsztener et al.,
2013). For our studies, we instead employed the equivalent of
the yeast Mia40F311E mutant, CHCHD4F68E (Figure 3A). This mu-
tation is far enough from the structural disulfides in CHCHD4 so
that it is not likely to affect CHCHD4 folding. Yeast Mia40F311E
also strongly hampered substrate accumulation but impaired
viability in Mia40 complementation experiments less severely
(Wrobel et al., 2013). All CHCHD4 variants were expressed to
similar levels. Exceptions were the F68E-based variants that
were present at lower levels, indicating that even this ‘‘mild’’
mutant might be affected in efficient folding (Figure 3B).
With theseCHCHD4 variants in hand, we tested the interaction
between CHCHD4 and its substrates in radioactive pulse-chase
assays, followed by denaturing or native IP of CHCHD4 variants
(Figures 3C and 3D). This assay allows testing the transient inter-Figure 3. Redox-Active Cysteines and theHydrophobic Groove in CHCH
Substrates
(A) Structure of CHCHD4 (PDB: 2K3J) and helix 2 of human COX17 (PDB: 2L0Y). C
Tanford hydrophobicity scale. The substrate is positioned on the hydrophobic g
alanine F68 is localized in the hydrophobic groove. Its mutation should disturb th
(B) Steady-state levels of CHCHD4 variants. Cells stably expressing CHCHD4-St
and lysates were analyzed by SDS-PAGE and immunoblot with the indicated an
(C and D) Pulse-chase analyses of CHCHD4-substrate interactions. HEK293
35S-methionine for 4 h. Then thiol exchange reactions were inhibited by addition o
IP (C, n = 2 biological replicates) or in 1% Triton X-100 for native IP (D, n = 1). T
reducing SDS-PAGE, and visualized by autoradiography. Disulfide-linked sub
CHCHD4WT and CHCHD4C53S interact with CHCHD4 substrates. CHCHD4 chap
(E) Summary of quantitative proteomics analysis (see Figures S3E–S3H an
hydrophobic binding groove are required. When comparing the C53S variant an
whereas most substrates appear to interact with both proteins to equal extent. T
replicates).action between CHCHD4 and its substrates that is lost upon
folding of proteins (Figure S3A). In denaturing IP with the
redox-incompetent variants of CHCHD4, we observed a strong
accumulation of proteins on wild-type CHCHD4 (Figure 3C,
lanes 2 and 7) comparedwithmock andCHCHD4C53S,C55S. Like-
wise, CHCHD4C53S co-precipitated many substrates (Figure 3C,
lanes 3 and 8). CHCHD4C55S did so to a much lesser extent (Fig-
ure 3C, lanes 4 and 9). This indicates that cysteine residue 55 is
likely the more reactive cysteine residue in the redox-active CPC
motif of CHCHD4. This is also in line with our finding that, in intact
cells, interaction between CHCHD4 and its reoxidizing enzyme
ALR (augmenter of liver regeneration) takes place via C55 (Fig-
ure S3B). We therefore provide in vivo evidence for previous
in vitro data (Banci et al., 2009, 2011; Koch and Schmid, 2014a).
Next we explored the interactome of the chaperone variants of
CHCHD4 in native IP with detergent concentrations we success-
fully employed before to analyze the interaction of CHCHD4 and
substrates (Petrungaro et al., 2015). We found that substrates
co-precipitated preferentially with wild-type CHCHD4 and not
with the redox-inactive or chaperone mutants (Figure 3D).
CHCHD4 variants were precipitated in similar amounts under
these conditions. Substrates likely interacted covalently via di-
sulfide bonds as they migrated at higher molecular weight than
CHCHD4 under non-reducing conditions but at lower molecular
weight after treatment with a reductant (compare Figure 3D,
lanes 2 and 7). These data indicate that the hydrophobic groove
in CHCHD4 is critical for initiation of disulfide-linked interactions.
This is also in line with previous in vitro data (Koch and Schmid,
2014b) but somewhat contradictory to an exclusive role of hy-
drophobic interactions in substrate import.
To furthermechanistically dissect the role of chaperone versus
redox function, we determined the redox state of CHCHD4F68E
using an inverse redox state determination assay (Erdogan
et al., 2018; Figure S3C). We found the CPC motif to be over-
whelmingly reduced (Figure S3D). This might be explained by
the mechanism of CHCHD4 reoxidation. It relies on ALR, which
has to interact with the hydrophobic groove in CHCHD4 to
perform reoxidation (Banci et al., 2011). Interfering with this inter-
action might prevent reoxidation and lead to a reduced CPC
motif. The presence of a partially reduced CPC motif might
also explain at least some of the experimental outcomes with
hydrophobic groove mutants of yeast Mia40 in the past thatD4Are Required for Formation ofMixedDisulfide Intermediateswith
olor-coding represents the hydrophobicity of the amino acids according to the
roove of CHCHD4, close to the redox-active cysteines C53 and C55. Phenyl-
e CHCHD4-substrate interaction.
rep variants were induced for 24 h with 1 mg/mL doxycycline. Cells were lysed,
tibodies. n = 4 biological replicates.
cells stably expressing CHCHD4-Strep variants were pulse-labeled with
f NEM to preserve mixed disulfides. Cells were lysed in 2% SDS for denaturing
hen lysates were subjected to IP against Strep, analyzed by non-reducing or
strate-CHCHD4 complexes and CHCHD4 substrates are indicated. Mainly
erone mutants fail to enrich substrates.
d Table S1 for detailed data). For substrate accumulation, C55 and the
d the wild-type, it appears that some substrates are more enriched on C53S,
he experiment was reproduced with inverted isotope labeling (n = 2 biological
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emphasized the importance of the hydrophobic groove over the
redox-active cysteine motif (Peleh et al., 2016; Wrobel et al.,
2013). Thus, both impaired reoxidation by ALR (and thus less
oxidized CHCHD4) and decreased substrate interaction appear
to underlie the lower efficiency of the CHCHD4F68E variant in the
formation of the metastable disulfide-linked CHCHD4-substrate
complex.
To specify our analyses, we combined different quantitative
proteomics approaches (Figures 3E and S3E–S3H; Table S1).
We compared differential accumulation of substrates on
CHCHD4 variants. These results supported the findings with
pulse-chase assays: cysteine 55 appeared to be most active in
substrate interaction (accumulation of substrates on C53S
compared with C55S), and the hydrophobic groove in CHCHD4
was required for accumulation of substrates compared with the
wild-type (accumulation of substrates on wild-type CHCHD4
compared with the F68E variant). Comparison of CHCHD4C53S
and CHCHD4WT indicated that most substrates were not en-
riched; i.e., both variants bound them to a similar extent. How-
ever, some proteins were enriched on CHCHD4C53S. A special
case is ALR, which, for CHCHD4 reoxidation, is targeted in a
nucleophilic attack by C55. Taken together, these results imply
that, in intact human cells, both the redox function and the
chaperone function of CHCHD4 are critical for interaction with
substrates.
CHCHD4F68E but Not Redox-Inactive CHCHD4 Variants
Partially Complement Lack of Endogenous CHCHD4
We next analyzed CHCHD4 redox and chaperone variants in
complementation experiments (Figure 4). To this end, we first
aimed to generate CHCHD4 knockout cells by employing
CRISPR-Cas9 gene editing using guide RNAs targeting different
sequences within the CHCHD4 gene. Transfected cells were
subsequently sorted, and CHCHD4 expression was examined
by western blotting (Figure 4A). Two clonal cell lines (clones #2
and #3) showed amarked reduction in CHCHD4 expression (Fig-
ure 4A), and genomic sequence analysis confirmed CRISPR-
Cas9-induced insertion or deletion (indel) mutations in CHCHD4.
Incomplete ablation of CHCHD4 expression in these cells may
rely on an inefficient cell sorting procedure or hemizygous
gene mutation in some sorted cells. Independently, reduced
CHCHD4 expression in these cells was associated with altered
substrate abundance (Figures 4B, 4C, and S4A). Some sub-Figure 4. The CHCHD4F68E Mutant, but Not CHCHD4 Cysteine Variants
(A) Schematic of the CRISPR-Cas9 strategy to target the CHCHD4 gene. Two g
forms of CHCHD4, CHCHD4.1 and CHCHD4.2) gave rise to clones #2 and #3, re
sequencing. Use of both guides led to incomplete loss of CHCHD4, as confirmed
of proteins.
(A–C) Levels of CHCHD4 substrates in CHCHD4 CRISPR-Cas9 clones. Cell lysa
logical replicates) and quantitative mass spectrometry (C, n = 3 biological replic
CHCHD4. Many are present at strongly decreased levels. An asterisk indicates th
indicates equal loading of proteins. (A) and (B) are derived from the same experi
(D) Complementation of CHCHD4 CRISPR-Cas9 clones with different CHCHD4 v
indicated variants of CHCHD4 or with the empty vector (Mock). Expression of CHC
lysed, and protein levels were analyzed by SDS-PAGE and immunoblot against t
and CHCHD4C53S,C55S, complemented loss of CHCHD4. CHCHD4F68E partially co
overexpression resulted in an increase in levels of selected substrates, and expres
COX17 and NDUFS5) even further. n = 2 biological replicates.strates like COX17 were almost completely lost, whereas others
like NDUFB10 were mildly affected. We then complemented the
cells with different CHCHD4 variants and tested again for sub-
strate levels as proxy for CHCHD4 function (Figures 4D and
S4B). We found that wild-type CHCHD4 complemented loss of
CHCHD4. Substrate levels were even slightly increased
compared with HEK293T cells (Figure 4D, compare lanes
1 and 3). Conversely, CHCHD4C53S (which we chose because
of its strong interaction with substrates) and CHCHD4C53S,C55S
could not complement CHCHD4 loss. Instead, it even appeared
that expression of CHCHD4C53S further decreased levels of
substrates (Figure 4D, compare lanes 2 and 4). Of note, the
expression of CHCHD4F68E could at least partially complement
the loss of CHCHD4. This indicates that, although in this mutant
interaction with substrates was impaired (Figure 3), the capacity
for mitochondrial import was still sufficient to partially rescue
substrate levels. Collectively, these experiments underline the
important role of redox-active cysteines in substrate import.
Mutations of Cysteines in CHCHD4 Are Deleterious for
Substrate Oxidation, Import, and Growth
CHCHD4C53S appeared to further decrease substrate levels in
the CHCHD4-CRISPR clone. To test whether this mutant exerts
a dominant-negative effect, we next investigated oxidation ki-
netics, substrate levels, and viability in wild-type cells overex-
pressing CHCHD4 variants. Under these conditions, substrate
oxidation kinetics were indeed affected (Figure 5A). Although,
for COX19, oxidation was extremely delayed in the presence of
all cysteine variants of CHCHD4, the behavior of endogenous
NDUFB7 was more graded. Expression of CHCHD4C55S and
CHCHD4C53S,C55S delayed NDUFB7 oxidation by about half
compared with CHCHD4WT. CHCHD4C53S expression exhibited
the strongest delay in oxidation. The differences in oxidation
delay caused by CHCHD4 variants indicated that CHCHD4C53S
and, to a somewhat lower extent, CHCHD4C55S and
CHCHD4C53S,C55S suppress the function of endogenous
CHCHD4.
We corroborated and extended our findings with an orthog-
onal experiment and assessed whether decreased substrate
oxidation rates result in lower steady-state substrate levels.
Therefore, we expressed different cysteine variants of CHCHD4
in wild-type HEK293 cells for 5 days and tested for levels of
diverse substrates. Again, we found that different substrates, Can Complement Lack of Endogenous CHCHD4
uides (#2 and #3) directed against the fourth exon of CHCHD4 (targeting both
spectively. Successful targeting of the gene by both guides was confirmed by
by immunoblot. n = 3 biological replicates. TCE staining indicates equal loading
tes were analyzed by immunoblot against the indicated proteins (B, n = 2 bio-
ates). Levels of CHCHD4 substrates are differentially affected by depletion of
e NDUFA8 signal from a preceding decoration of the membrane. TCE staining
ment and therefore have the same TCE loading control.
ariants. Cell lines were stably transfected with inducible plasmids harboring the
HD4 variants was induced for 5 days in glucose-containingmedium. Cells were
he indicated proteins. Expression of wild-type CHCHD4, but not CHCHD4C53S
mplemented compared with wild-type CHCHD4. Notably, wild-type CHCHD4
sion of CHCHD4C53S appeared to decrease the levels of some substrates (e.g.,
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were affected to very different degrees by the expression of
CHCHD4 variants (Figures 5B and 5C). Although we found that
expression of wild-type CHCHD4 generally led to increased
steady-state substrate levels compared with the mock control,
some substrates, like NDUFB10 and CHCHD3, hardly changed.
This supports the notion that, for many substrates, CHCHD4 is
normally present in amounts limiting import. Heterogeneity might
therefore stem from differences in substrate hydrophobicity,
expression levels, and translation and turnover rates. Overex-
pression of CHCHD4C53S,C55S, but also CHCHD4C55S, resulted
in decreased substrate levels for many proteins; some sub-
strates, like COX17, were almost completely depleted. Upon
overexpression of CHCHD4C53S, substrate levels were even
slightly more decreased (Figures 5B and 5C). Interestingly,
expression of the chaperone variant CHCHD4F68E did not result
in massively changed substrate levels (i.e., also not increased
levels; Figures S5A and S5B). Conversely, expression of
CHCHD4C53S, C55S, F68E showed decreased substrate levels
similar to the ones found for expression of CHCHD4C53S,C55S.
This also implies that the slightly decreased levels of this variant
compared, e.g., with the CHCHD4C53S,C55S variant, do not affect
its functional effect (Figure 3B). The findings that redox mutants
are deleterious for substrate accumulation and chaperone
mutants are not are in line with our observations in the comple-
mentation experiments (Figure 4).
To examine the degree of the dominant effect of CHCHD4C53S
overexpression in a complimentary unbiased approach, we
further employed quantitative proteomics (Figure 5D). Again,
CHCHD4WT overexpression resulted in increased levels of
multiple substrates, whereas CHCHD4C53S expression reduced
substrate levels. Of note, members of the twin CX3C family of
proteins (TIMM9, TIMM10, and TIMM13) were also affected by
expression of CHCHD4 variants (Figure 5D).
Expression of CHCHD4 cysteine mutants for 5 days on
glucose affected the steady-state levels of its substrates,
some of which are subunits or assembly factors of the respira-
tory chain. Therefore, we tested whether cell growth on galac-
tose, a carbon source requiring respiration, was affected. We
induced CHCHD4 variant expression for up to 7 days in cells
grown on galactose-containing medium and assessed cell
viability using the PrestoBlue assay. We found that overexpres-
sion of wild-type CHCHD4 and CHCHD4C53S,C55S did not affect
cell growth compared with non-induced cells (Figure 5E). Inter-
estingly, overexpression of the single mutants CHCHD4C53S
and CHCHD4C55S led to a strong decrease in cell growth afterFigure 5. CHCHD4 Cysteine Variants that Cannot Oxidize Their Substr
(A) In vivo oxidation assay of endogenous COX19 and NDUFB7 in HEK293 cells s
oxidation is impaired to different extents in the presence of different CHCHD4 cys
(B) Steady-state levels of CHCHD4 substrates in HEK293 cells stably expressing
induced for 5 days in glucose-containing medium. Cells were lysed, and protei
proteins. n = 2–3 biological replicates.
(C) Quantification of (B), showing substrate-specific differences in substrate leve
(D) Steady-state levels of CHCHD4 substrates in HEK293 cells stably expressing
5 days in glucose-containing medium. Cells lysates were analyzed by quantitati
generally increased, whereas in CHCHD4C53S-expressing cells, levels were decr
(E) Viability of cells upon overexpression of CHCHD4 cysteine variants. CHC
Expression of CHCHD4 variants was induced for 4 and 7 days in galactose-con
viability is presented as the viability data of induced cells divided by the data of7 days compared with non-induced cells. Expression of
CHCHD4C53S showed the strongest decrease in growth,
mirroring the effect on substrate steady-state levels. Cell
growth was not affected upon expression of CHCHD4F68E or
CHCHD4C53S, C55S, F68E (Figure S5C).
Loss of wild-type CHCHD4 oxidoreductase properties
resulted in deleterious dominant-negative effects for protein
oxidation and cell viability. How could CHCHD4 cysteine mu-
tants suppress the function of endogenous CHCHD4? First,
these mutants might displace endogenous CHCHD4 from
TOM pores (Fischer et al., 2013), and because they are not
capable of substrate oxidation (Figures S5D–S5F), substrates
would fail to accumulate in the IMS. However, this does not
explain the strong differences between the three mutants
(C53S, C55S, and C53S/C55S). The single mutants might still
be redox-active and act (especially CHCHD4C53S) as nucleo-
philes that attack themixed disulfide bond between endogenous
CHCHD4 and the substrate or already partially oxidized sub-
strates. To this end, they had to be in their reduced state. Using
the inverse redox state determination assay (Erdogan et al.,
2018; Figure S5G), we found that, indeed, both CHCHD4C53S
and CHCHD4C55S were completely reduced. We thus propose
that both C55 and C53 act as nucleophiles in the mutant back-
grounds that attack and destroy the metastable complex of sub-
strate and endogenous CHCHD4 or attack partially oxidized
substrates. In both scenarios, disulfide relay efficiency is
compromised. This is reflected by slower oxidation rates, lower
substrate levels, and decreased respiratory growth. C55 there-
fore constitutes the more dominant cysteine (also indicated by
the strong interaction with substrates of the CHCHD4C53S
mutant).
Collectively, based on our results with substrate and CHCHD4
mutants, we propose that substrates can follow two paths from
the initially formed metastable covalent substrate-CHCHD4
complex, one leading to productive disulfide formation and
another one resulting in the degradation of substrates and,
thus, decreased steady-state levels.
Failure of Productive Oxidation Results in IMS Release
and Proteasomal Degradation in the Cytosol
If productive substrate oxidation fails to proceed after formation
of the mixed disulfide intermediate between substrates and
CHCHD4, then substrates are apparently degraded. This is the
case for substrate cysteine variants (Figure 1G) but also for sub-
strates in the setting of CHCHD4 cysteine variant expressionates Are Deleterious for Oxidation, Import, and Growth
tably expressing different cysteine variants of CHCHD4. COX19 and NDUFB7
teine variants. Performed as described in Figure 1C. n = 2 biological replicates.
different cysteine variants of CHCHD4. Expression of CHCHD4 variants was
n levels were analyzed by SDS-PAGE and immunoblot against the indicated
ls.
wild-type CHCHD4 and CHCHD4C53S. Expression of CHCHD4 was induced for
ve mass spectrometry. In CHCHD4WT-expressing cells, substrate levels were
eased. n = 3 biological replicates.
HD4C53S and CHCHD4C55S exhibit the most severe effects on cell viability.
taining medium. Cells were analyzed by PrestoBlue cell viability reagent. Fold
non-induced cells of the same cell line. n = 3 biological replicates.
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(Figures 4 and 5). Thus, we next investigated the hypothesis that
this degradation takes place in the cytosol (Figure 6). To this end,
we first tested whether the proteasome, as the major cytosolic
degradation pathway, targets an MTS-COX19 cysteine variant
(Figure 6A). MTS-COX19 cysteine variants are processed in the
IMS, as indicated by cleavage of its MTS, and then are rapidly
degraded (Figures 1G and 6A). Treatment with the proteasomal
inhibitor MG132 strongly stabilized the processed form of the
MTS-COX19 cysteine variant, which is indicative of release of
the processed form from the IMS to the cytosol and subsequent
cytosolic degradation. In line with this, MG132-mediated stabili-
zation also resulted in the appearance of cytosolic COX19,
further supporting that processed MTS-COX19 is released
from the IMS and rapidly degraded in the cytosol (Figures 6B
and S6A).
Stabilization upon inhibition of proteasomal degradation
also took place for COX19, COA4, and NDUFB10 cysteine
variants without MTS (Figures 6C, 6D, and S6B–S6D). This
was not the case for the respective wild-type proteins
(Figures 6C, 6D, and S6B–S6E), indicating that, in human
cells, proteasomal degradation is indeed a mechanism
removing proteins that failed the ‘‘test’’ for efficient protein
oxidation in the IMS.
How could substrate release from the IMS be initiated? In
the IMS, reducing enzymes and the highly reducing gluta-
thione pool might contribute to resolving the mixed disulfide
bond between the substrate and CHCHD4 (Fischer et al.,
2013; Kojer et al., 2012). Although work in yeast has shown
that the IMS harbors glutaredoxins and thioredoxins, in the
mammalian IMS, only the glutaredoxin GRX1 was found (Pai
et al., 2007). If GRX1 influenced disulfide relay import, then
its overexpression should be deleterious for substrate accu-
mulation. Indeed, expression of IMS-targeted GRX1 led to
decrease of the CHCHD4 substrate COX17 (Figure S6F), the
substrate also most affected in assays with the dominant
CHCHD4C53S.
It is noteworthy that the degradation pattern appears to be
very different for the same COX19 variants with and without
MTS (compare Figures 1G and 6A with Figures 1D and 6C).
Substrates with an MTS appear to be degraded much faster.
Possibly, switching of the import pathway (MTS versus disul-
fide relay) might explain these more rapid degradation kinetics
of the MTS variants. MTS variants are more rapidly imported
(Fischer et al., 2013). One might speculate that faster import
and, therefore, loss of cytosolic chaperones results in faster
IMS release and degradation. By comparison, ‘‘normal’’
CHCHD4 substrates might stay longer in the cytosol before
entry into the IMS, resulting in increased apparent stability.
In our experiments, this would translate into less stable
MTS-COX19 variants.
Taken together, substrates that initially enter the IMS and
form a complex with CHCHD4 undergo cytosolic degradation
when they fail to become efficiently oxidized. This process is
likely facilitated by the vectorial nature of IMS protein
import. Release of substrates from CHCHD4 would take place
at a time when parts of the incoming substrate are still
exposed to the cytosol and, thus, could be extracted much
more easily.770 Cell Reports 26, 759–774, January 15, 2019DISCUSSION
A Redox Quality Control Step in Vectorial Oxidation-
Dependent Protein Import into the IMS
Here we present evidence for a redox-dependent ‘‘IMS import
quality control step’’ (Figure 6E). We propose that the vectorial
nature of substrate import and the capacity for productive disul-
fide formation in combination with the specific redox environ-
ment of the IMS form important determinants in this quality
control step. This redox quality control is likely embedded in a
network of pathways that maintain IMS protein homeostasis,
including the unfolded protein response activated by the mistar-
geting of proteins (UPRam) (Wrobel et al., 2015), mitochondrial
precursor overaccumulation stress (mPOS) (Wang and Chen,
2015), mitochondrial compromised protein import response
(mito-CPR) (Weidberg and Amon, 2018), and YME1 pathways
(Baker et al., 2012; Schreiner et al., 2012).
In our model of the redox-dependent IMS import quality
control step, a substrate coming from the cytosol partially
traverses the outer mitochondrial membrane (OMM), enters
the IMS, and initiates interaction with CHCHD4. Hydrophobic
interactions therefore orient the substrate for subsequent for-
mation of the mixed disulfide intermediate between CHCHD4
and its substrate. This intermediate has to persist until further
substrate cysteines enter the IMS. We propose that this time
span allows the intermediate to serve as a point for decision-
making toward either productive disulfide formation or cyto-
solic substrate degradation. This decision likely depends on
the IMS redox environment and IMS redox enzymes like gluta-
redoxins and thioredoxins (GRX1 is present in the human IMS
[Pai et al., 2007, and Trx1 is present in the yeast IMS proteome
[Vo¨gtle et al., 2012]). Alternatively, (premature) dissolution of
the disulfide in the intermediate might be driven by the second
(free) cysteine in CHCHD4 (e.g., C53). This is the reverse
reaction of the mixed disulfide bond formation leading to
the metastable CHCHD4 substrate intermediate. When the
CHCHD4-substrate complex is resolved without productive
oxidation, the substrate likely is still in transit across the
OMM, allowing it to slide back to the cytosol and undergo
degradation. This retrotranslocation probably occurs with the
help of cytosolic factors that prevent clogging of TOM pores
such as, in yeast, the protein Msp1 (in humans, ATAD1)
(Chen et al., 2014; Weidberg and Amon, 2018). Importantly,
Msp1/ATAD1 cannot remove substrates from mitochondria
that, in the IMS, covalently interact with a folded protein like
CHCHD4. Thus, disulfide reduction is a prerequisite for the
subsequent removal. The redox-dependent IMS import quality
control step therefore avoids accumulation of dead-end
CHCHD4 substrate intermediates in the TOM pore and mis-
folding-prone proteins (e.g., disease mutants lacking individual
cysteines) in the IMS. Moreover, such a mechanism would pre-
vent IMS accumulation of (mislocalizing) cytosolic proteins that
contain cysteines in a helical context. Thus, the disulfide relay
itself provides a layer of quality control for its substrates and
determines whether they are competent for folding and import.
With our study, we provide insights into the role of the protea-
some in IMS protein import. Previous studies in yeast proposed
the degradation of a significant share of proteins before even
Figure 6. Failure of Productive Oxidation Results in IMS Release and Proteasomal Degradation in the Cytosol
(A) Pulse-chase stability assay of MTS-COX19-C30S,C40S,C51S,C61S-HA in the presence of a proteasomal inhibitor. The destabilized MTS
variant C30S,C40S,C51S,C61S is stabilized by MG132 treatment. For proteasome inhibition, 5 mM MG132 was present throughout the pulse-chase
experiment. Performed as described in Figure 1C without maleimide modification. Expression was induced 1 h before the experiment with 1 mg/mL doxycycline.
n = 2 biological replicates.
(B) Localization ofMTS-COX19 cysteine variants in the presence and absence of proteasomal inhibitor. The experiment was performed as described in Figure 1E,
except that cells were cultured in the presence or absence of the proteasomal inhibitor MG132 at 5 mM for 4 h. Upon incubation with MG132, the cysteine variant,
but not the wild-type of COX19, accumulates in the cytosol. MitoTrackerRed was used to stain mitochondria (mito). Scale bar, 10 mm. WT, n = 35 cells;
C30,40,51,61S, n= 10 cells; technical replicates.
(C) Pulse-chase stability assay of COX19 cysteine variants. Cysteine variants, but not the wild-type, are stabilized by MG132 treatment. Performed as described
in (A). For proteasome inhibition, 5 mM MG132 was present throughout the pulse-chase experiment. n = 2 biological replicates.
(D) Steady-state levels of COX19 wild-type and cysteine variants. Cysteine variants are stabilized by MG132 treatment. For proteasome inhibition, cells were
treated with 5 mM MG132 for 4 h prior to cell lysis. (n = 2 biological replicates)
(E) Model for vectorial protein import by the mitochondrial disulfide relay and the redox quality control step that targets substrates for proteasomal degradation
after unsuccessful probing for oxidative folding (see Discussion for details).
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reaching the IMS and identified the required E2 and E3 machin-
ery for proteasomal targeting (Ubc4 and Rsp5) (Bragoszewski
et al., 2013; Kowalski et al., 2018). In mammalian cells, however,
such a massive influence on cytosolic CHCHD4 substrates en
route to mitochondria appears not to take place (Figures 6C,
6D, and S6B–S6E). Instead, we propose that the proteasome
only comes into action after substrates interact with CHCHD4
and fail to be oxidized and imported (Figure 6E). In this scenario,
proteasomal degradation is likely also supported by E2 and E3
ligases. These might well be the homologs of Ubc4 and Rsp5
(Kowalski et al., 2018).
Another layer of proteasomal surveillance of the IMS proteome
includes reduction and retrotranslocation of mature oxidized
proteins followed by their proteasomal degradation (Bragoszew-
ski et al., 2015). This process appeared to take place under very
specific conditions. It might well complement the Yme1-depen-
dent control of the mature IMS proteome that has been
proposed earlier (Baker et al., 2012; Schreiner et al., 2012), but
it is not connected to our proposed IMS import quality control
step and would take place at a later time point in the life of a
protein.
The Driving Force of CHCHD4-Dependent Import in
Intact Cells
Our work also provides insights into the driving force for IMS
import by the disulfide relay. Knowledge from structural and
in vitro experiments points to a mixture of hydrophobic and co-
valent interactions that initiate oxidative folding. Some models
emphasize rapid oxidation of proteins to retain them in the IMS
(‘‘folding trap model’’). Alternative models focus on the receptor
function of CHCHD4. They emphasize non-covalent interactions
to drive protein import and suggest that hydrophobic inter-
actions are sufficient for translocation (‘‘trans-site receptor
model’’). In this model, oxidation is a mere consequence of
IMS import and not required for the import process (Peleh
et al., 2016). However, we think that such models overstress
in vitro import experiments and neglect the lack of import effi-
ciency observed with these experiments. For example, the
import efficiency of cysteine-free Mia40 substrate mutants into
yeast mitochondria (Baker et al., 2012; Weckbecker et al.,
2012) is usually very low (<10%) compared with the efficient
protein import in intact cells. Likewise, import of substrates
into yeast mitochondria containing Mia40 only capable of hydro-
phobic interaction yielded very low import efficiencies (Peleh
et al., 2016). Moreover, in vitro import assays were performed
under oxidizing conditions (i.e., in a buffer under ambient
oxygen with redox conditions much more oxidizing than the
conditions in the highly reducing cytosol).
Our data, obtained mainly by experiments in intact cells, indi-
cate that hydrophobic interactions alone are, in general, not
capable of complementing the lack of disulfide formation.
Instead, we propose that, although hydrophobic interactions
guide substrate and CHCHD4 toward each other, the covalent
interactions in a dynamic metastable complex between
CHCHD4 and substrate and the following disulfide formation
are the main drivers of efficient protein import in intact cells.
This is also in line with the concepts proposed by previous
studies (Banci et al., 2009; Sideris et al., 2009; Koch and Schmid,772 Cell Reports 26, 759–774, January 15, 20192014b). Hydrophobic interactions alone might contribute to
import of very low amounts of proteins; e.g., proteins that have
to be dually localized and that otherwise would become targets
of the proposed IMS import quality control step.
Implications for Disease-Causing Substrate Mutants in
Human Patients
Our model is also in line with increasing evidence of hampered
import of disease mutants of CHCHD4 substrates (e.g.,
NDUFB10 [Friederich et al., 2017], TIMM8 [Hofmann et al.,
2002]), CHCHD10 [Lehmer et al., 2018], and COA6 [Baertling
et al., 2015]). Indeed, the patient mutant NDUFB10C107S fails to
accumulate in mitochondria despite interacting with CHCHD4 to
the same extent as the wild-type protein (Figure S1B). Conse-
quently, we also observed stabilization of this mutant by protea-
somal inhibition (Figure S6D). Thus, we propose that the
mentioned patient mutants of CHCHD4 substrates fail at the
‘‘redox quality control step’’ presented in this study.
Notably, tissue heterogeneity with respect to mitochon-
drial accumulation, which we observed, for example, for
NDUFB10C107S (Friederich et al., 2017), might indicate dif-
ferences in the IMS redox milieu, CHCHD4 levels, and
redox state and/or quality control and proteasomal activity.
This might also point to potential treatment strategies like
stimulation of CHCHD4 activity, increase in CHCHD4 levels,
suppression of the ubiquitin proteasome system, or
rendering the IMS a more oxidizing environment.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
For plasmids and cell lines used in this study, see Table S2. For the generation of stable, inducible cell lines the HEK293 cell
line–based Flp-In T-REx-293 cell line was usedwith the Flp-In T-REx system (Invitrogen). Cells were cultured in DMEMsupplemented
with 10% fetal bovine serum and penicillin/streptomycin at 37C under 5% CO2.
METHOD DETAILS
Pulse Chase Biogenesis assay
Pulse chase assays performed in this study were employed for different experiments. The assay to assess posttranslational
import (fractionation assay) and to assess protein oxidation in intact cells (oxidation assay) were performed as described previously
(Fischer et al., 2013). Newly synthesized proteins were pulse labeled with EasyTag EXPRESS 35S Protein Labeling Mix (Perkin Elmer)
at a concentration of 200 mCi/ml. In oxidation and fractionation assays the pulse labeling was stopped by addition of chase medium
containing 20 mM methionine and incubation for indicated times. The chase was stopped by adding ice-cold 8% TCA (oxidation
assay) or by addition of 0.003% digitonin to permeabilize selectively the plasmamembrane prior to addition of 8% TCA (fractionation
assay). After TCA precipitation the samples were resolved in modification buffer and either modified with mmPEG12/24 or left
untreated. For interaction assays performed as described in (Petrungaro et al., 2015) no chase medium was added. Instead, thiol
exchange reactions were stopped with 15mM NEM (N-Ethylmaleimide) dissolved in PBS at 4 C for 15min. Cells were then lysed
in SDS-sample buffer. Prior to immunoprecipitation samples were supplemented with 1% Triton X-100 and cleared by centrifugation
at 25,000 3 g for 1 h. Immunoprecipitation against protein of interest was carried out at 4C overnight under gentle shaking.
The samples were washed five times before elution with Laemmli buffer (2%SDS, 60mM Tris, pH 6.8, 10% glycerol, 0.0025%brom-
phenolblue) for 5 min at 95C. Samples were analyzed by Tris-Tricine PAGE (oxidation assay) or SDS-PAGE (fractionation assay) and
autoradiography.e2 Cell Reports 26, 759–774.e1–e5, January 15, 2019
In vitro oxidation kinetics
The in vitro oxidation kinetics assay was performed as described in (Bien et al., 2010). Synthesis of radiolabeled COX19 in vitro was
performed with the TNT Quick Coupled Transcription/Translation System (Promega). Radiolabeled COX19 was present in its
reduced state, as verified by alkylation assays. Prior to incubation with recombinant CHCHD4 variants the radioactive COX19 lysate
was diluted 60-fold. The reactionwas started by addition of CHCHD4 variants (30 mMfinal concentration). Sampleswere TCA-precip-
itated after indicated times. Pellets were resuspended in modification buffer (0.2M Tris, pH 7.5, 6M urea, 10mM EDTA, 2% SDS)
containing 15 mM mmPEG24 before incubation for 1 hr at 25C. Samples were analyzed by nonreducing SDS-PAGE and
autoradiography.
Immunofluorescence
The immunofluorescence assay was performed as described in (Fischer et al., 2013). In short, cells were cultured on poly-L-lysine
covered coverslips for 24 hr. Fixation was performed with 4%paraformaldehyde for 15 min. Permeabilization of cell membranes was
performed with blocking buffer [20 mMHEPES pH 7.4, 3% BSA, 0.3% Triton X-100] for 1 hr. After washing cells were incubated with
primary (anti-HA, anti-Strep, anti-cytochrome c) and secondary antibodies (anti-rat, ALEXA488; anti-mouse, ALEXA594) for 1 hr,
respectively. Nuclei were stained for 15min with 2 ng/ml DAPI in PBS. Then, cells were washed, coverslips transferred tomicroscope
slides (covermedium: 30%glycerol, 12%polyvinyl alcohol, 60mMTRIS, 2.5%1,4-diazabicyclo-2,2,2-octan) and analyzed by immu-
nofluorescence microscopy. For microscopic images in Figures 1 and 2 the following setup was used: Zeiss Axioskop2, Zeiss
Plan-Neofluar 100x/ 1.30/ oil, F-FiewCool Snap, CellF imaging software. Formicroscopic images in Figure 6, S2, and S6 the following
setup was used: Leica Microsystems TCS SP8 (Inverse, DMi 8 CS), PL Apo 63x/1.40 Oil CS2, LAS X.
Stable Isotope Labeling in Cell Culture and Mass Spectrometric Analysis
Stable Isotope Labeling in Cell Culture (SILAC) was performed as described in (Petrungaro et al., 2015). The collected beads were
heated in SDS-PAGE loading buffer containing 1mMDTT for 10 min at 95C. After alkylation using 5.5 mM iodoacetamide for 10 min
at room temperature the samples were centrifuged and the supernatants were loaded on 4%–12% gradient gels (NuPAGE, Thermo
Fisher) for protein separation. After staining, each gel lane was cut into 5-10 slices, the proteins were in-gel digested with trypsin
(Promega) and the resulting peptide mixtures were processed on STAGE tips and analyzed by LC-MS/MS (Rappsilber et al.,
2007; Shevchenko et al., 2006). The LC-MSmeasurements were performed on aQExactive Plus or HF-Xmass spectrometer coupled
to an EasyLC 1000/1200 nanoflow-HPLC. Peptides were separated on fused silica HPLC-column tip (I.D. 75 mm,NewObjective, self-
packed with ReproSil-Pur 120 C18-AQ, 1.9 mm (Dr. Maisch) to a length of 20 cm) using a gradient of A (0.1% formic acid in water) and
B (0.1% formic acid in 80% acetonitrile in water): loading of sample with 0% B with a flow rate of 600 nl/min; separation ramp from
5%–30% B within 85 min with a flow rate of 250 nl/min).For nanoESI the spray voltage was set to 2.3 kV and ion-transfer tube tem-
perature to 250C, no sheath and auxiliary gas was used. The mass spectrometer was operated in the data-dependent mode; after
eachMS scan (mass rangem/z = 370 – 1750; resolution: 70000) amaximum of tenMS/MS scans were performed using a normalized
collision energy of 25%, a target value of 1000 and a resolution of 17500. The MS raw files were analyzed using MaxQuant Software
version 1.4.1.2 (Cox and Mann, 2008) for peak detection, quantification, and peptide identification using a full-length UniProt human
database (March, 2016) and common contaminants such as keratins and enzymes used for in-gel digestion as reference. Carbami-
domethylcysteine was set as fixed modification and protein amino-terminal acetylation and oxidation of methionine were set as
variablemodifications. TheMS/MS tolerancewas set to 20 ppm and threemissed cleavageswere allowed using trypsin/P as enzyme
specificity. Peptide and protein FDR based on a forward-reverse database were set to 0.01, minimum peptide length was set to
7, and minimum number of peptides for identification of proteins was set to one, which must be unique. The ‘‘match-between-
run’’ option was used with a time window of 1 min.
Assay to address inverse and direct redox states of protein thiols
The redox state assay was performed as described in (Erdogan et al., 2018). Reduced thiols were blocked by treatment with 15mM
NEM (N-Ethylmaleimide) dissolved in PBS at 4 C for 15min for minimal shift (min) and steady-state (ss) samples. Max shift (max)
samples were treated with PBS at 4 C for 15min. Thiol-exchange reactions were stopped by addition of 8% ice cold TCA. TCA pre-
cipitation of proteins was performed by centrifugation at 13,000 3 g for 15min and washing with 5% TCA. Protein precipitates were
dissolved in 40 ml of modification buffer by sonication and treated with 5mM TCEP (Tris(2-carboxyethyl)phosphine) for 15min at 4 C
beforemmPEG24modification (15 mMfinal concentration). For min shift controlsmmPEG24was omitted. After modification samples
were filled to 100 ml with ddH2O and Laemmli buffer (2%SDS, 60mMTris, pH 6.8, 10%glycerol, 0.0025%bromphenol blue) and 10 ml
of sample was loaded and analyzed on SDS-PAGE, western blotting, and immunodetection.
Generation of CHCHD4 CRISPR clones
Guide RNA Sequences (#2: CCTCATCCTCTTGGGGATAG, #3: CCTCTATCCCCAAGAGGATG) targeting human CHCHD4 were
cloned into the pSpCas9(BB)-2A-GFP (PX458) vector, which was a gift from Feng Zhang (Addgene plasmid # 48138) (Ran et al.,
2013). HEK293T cells were transfected using Lipofectamine 2000 (Thermo Fisher Scientific). After 24 hr, GFP-positive cells were
collected via FACS and single cell clones were seeded onto 96-well plates (1 cell / well). Clonal cell lines were screened for CHCHD4
protein expression by western blotting and sequenced to verify indel mutations (by Eurofins GATC Biotech).Cell Reports 26, 759–774.e1–e5, January 15, 2019 e3
Complementation of CHCHD4 CRISPR clones
CHCHD4 CRISPR clones were complemented with different CHCHD4 variants by using the inducible PiggyBac Transposon Vector
System. Different CHCHD4 constructs were cloned into the PB-CuO-MCS-IRES-GFP-EF1-CymR-Puro vector and co-transfected
with the Super PiggyBac Transposase Expression Vector into the CHCHD4 CRISPR clones by using the transfection reagent
FuGene, according to the manufacturer’s guideline. After two days, positive clones were selected with 2 mg/ml puromycin in
glucose-containing medium.
Western blot analysis for CHCHD4-substrates
HEK293 cells expressing either empty plasmid (Mock) or different CHCHD4-Strep variants, HEK293T CHCHD4 CRISPR clones and
HEK293T CHCHD4 CRISPR clones expressing either the empty plasmid (Mock) or different CHCHD4 variants (PiggyBac system)
were seeded on 10 cm dishes in glucose-containing medium. After 24 h, the medium was supplemented with doxycycline (Flp-In
system) or cumic acid (PiggyBac system) to induce expression of the CHCHD4 variants. No chemical was added to the
non-complemented HEK293T CHCHD4 clones. After five days, cells were washed with PBS and lysed in LCW buffer (0.5%
Triton X-100, 0.5% sodium deoxycholate, 150 mM NaCl, 20 mM Tris-HCl pH7.5, 10 mM EDTA, 30 mM sodium pyrophosphate,
protease inhibitor cocktail (Sigma)). Lysates were incubated for 30 min on ice and cleared by centrifugation at 20.000 x g for
30 min at 4C. Protein concentration of supernatants was determined with BCA assay (Roth) and 50 mg per lane were analyzed
by SDS-PAGE.
Quantitative label-free proteomics
The day before the experiment, cells were seeded on 6-well dishes. The next day, the medium was replaced with DMEM containing
1mg/ml doxycycline induce CHCHD4 variant expression. The cells were incubated for 5 days. After 5 days, medium was removed,
cells were washed oncewith PBS, scratched of in 1mLPBS and transferred to a 1.5mL reaction tube. After centrifugation at 500 g for
5 min, PBS was removed and the cell pellets were resuspended in 20 ml lysis buffer (4% SDS in PBS containing protease inhibitor).
Then the solution was sonified and incubated for 5 min at 96C. To precipitate proteins, 160 ml of acetone were added and the
samples were frozen at20C overnight. After centrifugation for 15 min at 16.000 g, the pellet was washed once with 500 ml acetone
and then air-dried. For Iin solution digest the pellet was resuspended in 50 ml 8 M Urea in TEAB buffer supplemented with protease
inhibitor cocktail. To completely resolve the pellet, sampleswere sonified. To remove cell debris, samples were centrifuged for 15min
at 20.000 g. The protein concentration of the supernatant was determined using Pierce 660nm Protein Assay Reagent. 50 mg were
transferred to a new reaction tube and filled up to 50 ml with the Urea/TEAB buffer. DTT (5mM end-concentration) was added and the
samples were incubated for 1 h at 37C. Iodoacetamid (40mMend-concentration) was added and the samples were incubated in the
dark for 30 min. Then, Lysyl Endopeptidase with an enzyme to substrate ratio of 1:75 was added, followed by incubation for 4 h at
25C. Next, the samples were diluted using TEAB buffer to reach a urea concentration below 2 M. Then, trypsin with an enzyme to
substrate ratio of 1:75 was added and the samples were incubated at 25C overnight. To purify the samples, STAGE tips were equil-
ibrated with methanol and buffers containing 0.1% formic acid and 80% acetonitrile. The samples were loaded on the STAGE tips
and then washed with the same buffers. After complete drying, the STAGE tips were stored at 4C until MS analysis, which was per-
formed by proteomics core facility cologne.
All samples were analyzed on a Q Exactive Plus Orbitrap (Thermo Scientific) mass spectrometer that was coupled to an EASY nLC
‘‘LC’’ (Thermo Scientific). Peptides were loaded with solvent A (0.1% formic acid in water) onto an in-house packed analytical column
(‘‘50 cm— 75 mm I.D., filled with 2.7 mmPoroshell EC120 C18, Agilent’’). Peptides were chromatographically separated at a constant
flow rate of 250 nL/min using the following gradient: 3%–5%solvent B (0.1% formic acid in 80%acetonitrile) within 1.0min, 5%–30%
solvent B within 91.0 min, 30%–50% solvent B within 17.0 min, 50%–95% solvent B within 1.0 min, followed by washing and column
equilibration. The mass spectrometer was operated in data-independent acquisition mode. The MS1 scan was acquired from
400-1220 m/z at a resolution of 140,000. MSMS scans were acquired for 10 DIA windows at a resolution of 35,000. The AGC target
was set to 3e6 charges. The default charge state for the MS2 was set to 4. Stepped normalized collision energy was set to 23.5%,
26%, 28.5%. The MSMS spectra were acquired in profile mode.
Viability assay
The viability of cells in galactose-containing medium (DMEM supplemented with 4.5 g/l galactose, 1 mM sodium pyruvate, 1 x non-
essential amino acids, 10% fetal calf serum and 500 mg/ml Pen/Strep) was determined using the PrestoBlue Cell Viability Reagent
(Thermo). Galactose adapted HEK293 cells were seeded on 96-well dishes. After 24 h, medium containing doxycycline was added to
‘+dox-samples’ to induce exogenous gene expression. ‘- dox-samples’ were supplemented with medium without doxycycline. Cell
viability was assessed either directly after addition of doxycycline (0 days) or after 3 or after 7 days. Each day, the cells were supple-
mented with fresh medium containing either doxycycline or not. The viability assay was performed according to the manufacturer’s
protocol. In short, PrestoBlue Cell Viability Reagent was added to the cells in medium. After incubation for 1 h at 37C, the fluores-
cence was measured at excitation and emission wavelengths of 560 nm and 590 nm, respectively. After subtracting fluorescence
values ofmedium-only samples the fluorescence values of samples treatedwith doxycycline were divided by the fluorescence values
of samples treated without doxycycline to compare effects of exogenous gene expression.e4 Cell Reports 26, 759–774.e1–e5, January 15, 2019
Chemical treatments
To inhibit the proteasome cells were supplemented with medium containing 5 mM MG132. For western blot analysis, cells were
treated for 16 h, while in pulse chase experiments treatment with MG132 started during the starvation period.
Structure modeling
COX19 (Uniprot: Q49B96) and COA4 (Uniprot: Q9NYJ1) were modeled onto the solution structure of the twin CX9C protein CHCHD7
(PDB: 2LQT) using SWISS-MODEL (Waterhouse et al., 2018). NDUFB10 structure was retrieved from the Cryo-EM structure of hu-
man respiratory complex I transmembrane arm (PDB: 5XTC). Structures were visualized with PyMol.
Hydrophobicity scaling and hierarchical clustering
Amino acids in twin CX9C motifs were scored for hydrophobicity using the Tanford scale (Whitney and Tanford, 1962). Data were
grouped using hierarchical clustering (metric: euclidean distance; linkage method: average) and plotted in a heatmap using
Morpheus (https://software.broadinstitute.org/morpheus/). Logoplot was created using Weblogo (https://weblogo.berkeley.edu/).
QUANTIFICATION AND STATISTICAL ANALYSIS
Intensity of autoradiography and immunoblot signals were quantified using ImageQuantTL (GE) and Image Lab (Biorad), respectively.
Microscope images were processed with Fiji. For SILAC MS data interpretation, Perseus software was used (Tyanova et al., 2016).
Interacting proteins were identified by performing outlier tests (Significance A) taking a p value of 0.05, BH corrected, as cut-off. Error
bars in figures represent standard deviation. The number of experiments is reported in the figure legend.Cell Reports 26, 759–774.e1–e5, January 15, 2019 e5
